Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

TYO:4538 Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Cash & Equivalents	4,574	4,846	6,264	5,120	9,120	4,278
Cash & Short-Term Investments	4,574	4,846	6,264	5,120	9,120	4,278
Cash Growth	44.88%	-22.64%	22.34%	-43.86%	113.18%	11.61%
Receivables	23,699	26,897	26,491	24,328	22,613	19,442
Inventory	15,835	15,682	14,941	14,202	8,247	7,345
Prepaid Expenses	-	331	275	275	-	-
Other Current Assets	9,977	9,580	371	1,022	166	299
Total Current Assets	54,085	57,336	48,342	44,947	40,893	32,114
Property, Plant & Equipment	22,170	22,185	23,110	24,424	22,490	23,717
Long-Term Investments	9,916	5,332	4,375	3,924	8,067	5,499
Other Intangible Assets	1,298	1,352	1,513	600	376	166
Long-Term Deferred Tax Assets	-	2,572	296	396	-	-
Other Long-Term Assets	2	1,546	1,417	1,511	3	2
Total Assets	87,471	90,323	79,053	75,802	71,849	61,528

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Accounts Payable	4,420	4,067	3,998	7,352	12,178	11,347
Accrued Expenses	480	1,724	1,765	1,318	996	809
Short-Term Debt	26,339	29,012	22,630	12,413	6,920	6,713
Current Portion of Long-Term Debt	-	604	827	3,351	100	100
Current Portion of Leases	-	-	-	-	2	1
Current Income Taxes Payable	116	103	949	270	3,606	1,595
Other Current Liabilities	16,821	16,174	5,218	4,946	3,733	3,707
Total Current Liabilities	48,176	51,684	35,387	29,650	27,535	24,272
Long-Term Debt	1,822	1,858	2,462	7,021	6,191	6,679
Long-Term Leases	-	-	-	-	4	-
Pension & Post-Retirement Benefits	-	177	506	889	1,577	1,488
Long-Term Deferred Tax Liabilities	-	1,354	1,315	1,315	2,750	2,208
Other Long-Term Liabilities	1,722	193	272	266	695	282
Total Liabilities	51,720	55,266	39,942	39,141	38,752	34,929

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Common Stock	10,758	10,758	10,758	10,758	10,758	10,758
Additional Paid-In Capital	14,951	14,951	14,951	14,951	15,010	15,010
Retained Earnings	14,139	13,881	18,680	16,541	10,841	6,201
Treasury Stock	-2,595	-2,595	-2,593	-2,588	-1,414	-1,409
Comprehensive Income & Other	-1,502	-1,938	-2,685	-3,001	-2,098	-3,961
Shareholders' Equity	35,751	35,057	39,111	36,661	33,097	26,599
Total Liabilities & Equity	87,471	90,323	79,053	75,802	71,849	61,528

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Total Debt	28,161	31,474	25,919	22,785	13,217	13,493
Net Cash (Debt)	-23,587	-26,628	-19,655	-17,665	-4,097	-9,215
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2762.66	-3118.54	-2300.83	-2051.55	-452.52	-1017.64
Filing Date Shares Outstanding	8.54	8.54	8.54	8.61	9.05	9.05
Total Common Shares Outstanding	8.54	8.54	8.54	8.61	9.05	9.05
Working Capital	5,909	5,652	12,955	15,297	13,358	7,842
Book Value Per Share	4188.10	4106.45	4579.55	4257.67	3656.06	2937.67
Tangible Book Value	34,453	33,705	37,598	36,061	32,721	26,433
Tangible Book Value Per Share	4036.05	3948.08	4402.39	4187.99	3614.52	2919.33
Land	-	8,820	8,818	8,818	-	-
Buildings	-	34,918	34,746	34,599	-	-
Machinery	-	34,866	34,521	33,985	-	-
Construction In Progress	-	616	174	246	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error